Doculabs

Effective management of content is critical for organizations in the pharmaceutical industry, where intellectual capital resides in a company’s documentation. Research and development requires tools to facilitate innovation, collaboration, and sharing of documents. Clinical trials can benefit from more effective ways to disseminate and gather information from trial participants. Accelerating the process of preparing New Drug Applications for submission to regulatory authorities requires validated systems that meet strict compliance requirements for documentation generated in clinical trials. The intellectual property – the work product of pharmaceutical research and development – also needs to be managed over the longer term, potentially throughout the lifecycles of an organization’s patents. There is also increasing demand to address the digitization of the paper involved in certain business processes, to facilitate the sharing of information with partners and suppliers.

Doculabs understands the unique content management challenges that you face in the pharmaceutical industry, as well as the role that technology can play in addressing those challenges. Your business processes are highly content-intensive, with stringent requirements for technologies and for policies and procedures to facilitate retention, search and retrieval – particularly for audit and for litigation e-discovery. Pharmaceutical firms are also good candidates for business process automation, whether through the workflow capabilities of an ECM solution or the comprehensive process management capabilities of business process management (BPM) tools.

In our 17-year history, we’ve helped many organizations in the pharmaceutical industry address these and other content-related challenges. We can work with you to improve your own processes and help you make more effective use of your intellectual capital.

For more information, please contact us.